Skip to main content
. 2019 May 4;9(10):2924–2938. doi: 10.7150/thno.35274

Figure 5.

Figure 5

A) HE, PSMA, caspase-3, ƴH2aX, and Ki-67 stainings of s.c. PSMA+ LS174T-PSMA tumors after i.v. administration of PBS (left) or 80 µg of 111In-DTPA-D2B-IRDye700DX (middle (tumors dissected 1h after tPDT) and right (tumors dissected 24h after tPDT)). All scale bars indicate 500 µm. B) Staining intensity of immunohistochemical stainings of treated (n=5) and non-treated tumor.